EP1196187A4 - Keratinocyte growth factor-2 formulations - Google Patents

Keratinocyte growth factor-2 formulations

Info

Publication number
EP1196187A4
EP1196187A4 EP00941186A EP00941186A EP1196187A4 EP 1196187 A4 EP1196187 A4 EP 1196187A4 EP 00941186 A EP00941186 A EP 00941186A EP 00941186 A EP00941186 A EP 00941186A EP 1196187 A4 EP1196187 A4 EP 1196187A4
Authority
EP
European Patent Office
Prior art keywords
formulations
growth factor
keratinocyte growth
keratinocyte
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00941186A
Other languages
German (de)
French (fr)
Other versions
EP1196187A1 (en
Inventor
Reiner L Gentz
Arvind Chopra
Parveen Kaushal
Thomas Spitznagel
Edward Unsworth
Fazal Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1196187A1 publication Critical patent/EP1196187A1/en
Publication of EP1196187A4 publication Critical patent/EP1196187A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00941186A 1999-06-02 2000-06-02 Keratinocyte growth factor-2 formulations Withdrawn EP1196187A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13744899P 1999-06-02 1999-06-02
US137448P 1999-06-02
US16091399P 1999-10-22 1999-10-22
US160913P 1999-10-22
PCT/US2000/015186 WO2000072872A1 (en) 1999-06-02 2000-06-02 Keratinocyte growth factor-2 formulations

Publications (2)

Publication Number Publication Date
EP1196187A1 EP1196187A1 (en) 2002-04-17
EP1196187A4 true EP1196187A4 (en) 2003-02-05

Family

ID=26835257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00941186A Withdrawn EP1196187A4 (en) 1999-06-02 2000-06-02 Keratinocyte growth factor-2 formulations

Country Status (9)

Country Link
EP (1) EP1196187A4 (en)
JP (1) JP2003500456A (en)
KR (1) KR20020010920A (en)
CN (1) CN1359299A (en)
AU (1) AU5593200A (en)
CA (1) CA2375829A1 (en)
HK (1) HK1045816A1 (en)
MX (1) MXPA01012387A (en)
WO (1) WO2000072872A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
EP1041996A4 (en) 1997-12-22 2003-05-14 Human Genome Sciences Inc Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
CA2320515A1 (en) 1998-02-13 1999-08-19 Human Genome Sciences, Inc. Therapeutic uses of keratinocyte growth factor-2
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
EP1684816B1 (en) 2003-10-28 2009-05-06 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
JP2007534633A (en) * 2003-11-10 2007-11-29 アライバ−プロメティック インコーポレイティド Human alpha 1-antitrypsin preparation
BRPI0519070A2 (en) * 2004-12-15 2008-12-23 Amgen Inc lyophilized keratinocyte growth factor composition, methods for preparing a lyophilized keratinocyte growth factor, and for treating a disease, and kit for preparing an aqueous pharmaceutical composition
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN100434117C (en) * 2006-06-06 2008-11-19 武汉大学 Suppository for treating chronic cervicitis
JP5272126B2 (en) 2006-06-29 2013-08-28 リンク・ジェノミクス株式会社 Antibiotic injection and administration liquid
JP2011507816A (en) * 2007-12-21 2011-03-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Malaria vaccine
CN101642576B (en) * 2008-08-05 2011-08-17 温州医学院 Polyethylene glycol-modified product of KGF-2 and preparation method thereof
CN101537172B (en) * 2008-08-14 2010-06-30 温州医学院 Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same
WO2011011808A1 (en) * 2009-07-30 2011-02-03 Roman Buga A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid
CN102727890A (en) * 2012-07-05 2012-10-17 吉林农业大学 Application of anti-recombinant human keratinocyte growth factor-2 antibody
WO2016138362A1 (en) * 2015-02-26 2016-09-01 The Board Of Trustees Of The University Of Arkansas Treatment vaccine for prostate cancer
CN106377760A (en) * 2016-10-26 2017-02-08 李天学 Application of preparation containing KGF-2 (keratinocyte growth factor-2) to relieving of diabetic ulcer
CN108338967B (en) * 2017-09-15 2020-11-20 浙江唯美生物科技有限公司 Collagen sustained-release hydrogel containing fibroblast growth factor 10
CN112512504A (en) * 2018-06-22 2021-03-16 温州医科大学 Hydrogel, pharmaceutical composition containing hydrogel and application of pharmaceutical composition

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518697A2 (en) * 1991-06-14 1992-12-16 Amgen Inc. Collagen film for sustained delivery of proteins
EP0619115A1 (en) * 1993-04-01 1994-10-12 Amgen Inc. Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
WO1998006844A1 (en) * 1996-08-13 1998-02-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
WO1998016642A1 (en) * 1996-10-15 1998-04-23 Amgen Inc. Keratinocyte growth factor-2 products
WO1998016243A1 (en) * 1996-10-15 1998-04-23 Amgen Inc. Uses of keratinocyte growth factor-2
US5814605A (en) * 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
WO1999032135A1 (en) * 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518697A2 (en) * 1991-06-14 1992-12-16 Amgen Inc. Collagen film for sustained delivery of proteins
US5814605A (en) * 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
EP0619115A1 (en) * 1993-04-01 1994-10-12 Amgen Inc. Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
WO1998006844A1 (en) * 1996-08-13 1998-02-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
WO1998016642A1 (en) * 1996-10-15 1998-04-23 Amgen Inc. Keratinocyte growth factor-2 products
WO1998016243A1 (en) * 1996-10-15 1998-04-23 Amgen Inc. Uses of keratinocyte growth factor-2
WO1999032135A1 (en) * 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0072872A1 *

Also Published As

Publication number Publication date
MXPA01012387A (en) 2002-08-23
EP1196187A1 (en) 2002-04-17
AU5593200A (en) 2000-12-18
CN1359299A (en) 2002-07-17
HK1045816A1 (en) 2002-12-13
KR20020010920A (en) 2002-02-06
CA2375829A1 (en) 2000-12-07
JP2003500456A (en) 2003-01-07
WO2000072872A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
EP1196187A4 (en) Keratinocyte growth factor-2 formulations
AU2002309473A1 (en) Keratinocyte growth factor-2
PL350796A1 (en) Compositions for promoting growth
HUP0102482A3 (en) Formulations for controlling human lice
DE69934298D1 (en) GROWTH FACTORS CONTAINING PROSTHESIS
GB9804013D0 (en) Formulations
GB9812103D0 (en) Surgical implant
IL147253A0 (en) Growth hormone formulations
IL132625A0 (en) Composition for inducing hair growth
EP1054900A4 (en) Therapeutic uses of keratinocyte growth factor-2
GB9924959D0 (en) Implant alignment
GB9815002D0 (en) Formulations
GB9815001D0 (en) Formulations
EP1373299A4 (en) Connective tissue growth factor-2
AU137971S (en) Implant
AU2003203859A1 (en) Keratinocyte growth factor-2 formulations
ZA987083B (en) Hair growth formulation
GB9922300D0 (en) Disinfectant composition
GB9916252D0 (en) Growth hormone formulation
AU1907500A (en) Compositions and methods for disinfecting fabric
GB9905907D0 (en) Sterilant composition
HU9900222V0 (en) Dental implantation structure
GB9823253D0 (en) Disinfectant formulation
GB9918902D0 (en) Growth hormone formulation
GB0014097D0 (en) Remedy for natural hair growth

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20021219

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040624

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1045816

Country of ref document: HK